09/02/2020 12:00 AM EDT
Source: National Emerging Special Pathogens Training and Education Center (NETEC). Published: 9/2/2020. COVID-19 testing strategies impact overall hospital operations, including the need for cohorting any amount of personal protective equipment used. Review the guidelines on this page to help balance the safety and efficacy of testing at your facility. (Text)
09/01/2020 12:00 AM EDT
Source: United Kingdom Department of Health (DH). Published: 9/2020. This 600-page book, updated on September 1, 2020, was designed to help manage the recovery phase of a chemical incident where contamination has affected food production systems, inhabited areas, and water environments. (PDF)
09/01/2020 12:00 AM EDT
Source: Henry J. Kaiser Family Foundation. Published: 9/1/2020. This analysis examines the impact of COVID-19 on assisted living facilities, as well as changes over time, using state-level data on COVID-19 cases and deaths reported in early June 2020, and again in early August. (Text)
09/01/2020 12:00 AM EDT
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 9/2020. This web page provides a list of videos from the Strategic National Stockpile that are designed to assist in the assembly and/or operation of key components and equipment in the Federal Medical Station deployment cache. (Video or Multimedia)
08/31/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 8/31/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the BayCare SARS-CoV-2 RT PCR Assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The BayCare SARS-CoV-2 RT PCR Assay is authorized for use on nasopharyngeal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
08/31/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 8/31/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the SARS-CoV-2 DETECTR Reagent Kit. The SARS-CoV-2 DETECTR Reagent Kit is authorized for use with upper respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
08/31/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 8/31/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the MiraDx SARS-CoV-2 RT-PCR assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
08/31/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 8/31/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the T2SARS-CoV-2 Panel. The T2SARS-CoV-2 Panel is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
08/31/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 8/31/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the COVID-19 ELISA pan-Ig Antibody Test. The COVID-19 ELISA pan-Ig Antibody Test is authorized for the detection of antibodies to SARS-CoV-2 in human serum. (PDF)
08/31/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 8/31/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the TBG SARS-CoV-2 IgG/IgM Rapid Test Kit. The TBG SARS-CoV-2 IgG/IgM Rapid Test Kit is authorized for the detection of antibodies to SARS-CoV-2 in human serum and plasma (Acid Citrate Dextrose -ACD). (PDF)
08/31/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention (CDC). Published: 8/31/2020. This one-page flowchart details what to do if a student becomes sick at school, reports a new COVID-19 diagnosis, or tests positive or negative. (PDF)
08/24/2020 12:00 AM EDT
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 8/24/2020. This web page provides training on the use of ventilator models held in the Strategic National Stockpile. (Text)
08/07/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention (CDC). Published: 8/7/2020. This Law and Epidemic Emergency Preparedness (LEEP) training covers provisions and concepts applicable to epidemic response, including various challenges faced during the 2014 Ebola response, and applies them to future infectious disease emergency response planning. LEEP examines legal underpinnings of emergency preparedness and response systems, what actions are authorized, and how to minimize legal barriers to an effective large-scale communicable disease response. (Video or Multimedia)
08/01/2020 12:00 AM EDT
Source: National Child Traumatic Stress Network (NCTSN). Published: 8/2020. This two-page fact sheet provides information for youth about separation distress, when separation can be traumatic for children and youth, traumatic reactions to separation, and what to do to feel better. (PDF)
08/01/2020 12:00 AM EDT
Source: National Child Traumatic Stress Network (NCTSN). Published: 8/2020. This two-page fact sheet offers information for youth to help them understand the differences between grief and traumatic grief, the signs and symptoms of traumatic grief in children and youth, and what to do to feel better. (PDF)
07/27/2020 12:00 AM EDT
Source: Johns Hopkins University. Published: 7/27/2020. Speakers in this one-hour webinar discuss what school-based health care provides, issues for school-based health care and COVID-19, and the role of school health during COVID-19 closing and re-entry. (Video or Multimedia)
06/05/2020 12:00 AM EDT
Source: University of California, San Francisco (UCSF). Published: 6/5/2020. This is a self-report, administered questionnaire collected via REDCap (Research Electronic Data Capture system) to assess the costs and socioeconomic consequences of non-pharmaceutical public health interventions to mitigate community transmission of COVID-19 such as stay-at-home/shelter-in-place, self-isolation, and quarantine on high-risk populations (primarily those who are low-income, non-U.S. born, or for whom English is a second language). This survey is to be administered to all participants who have not had symptoms consistent with COVID-19. This includes participants who may have been quarantined due to being in contact with a person with confirmed COVID-19, but they themselves do not or have not had the disease. Questions and answers of this section should reflect ALL costs related to social distancing, quarantine, and shelter-in-place orders, including lost income, housing instability, and food insecurity. All of the questions are referring to the time period of the shelter-in-place order during which all individuals are asked to stay at home except for those who are considered essential workers or to do essential activities like grocery shopping or accessing health services from March 19 to May 31, 2020. Population: Adult Workers Adults Only Length: Approximately 30 questions Time to Complete: 20 minutes Mode of Administration: Face-to-face Telephone Administered by: Trained Lay Examiner/Interviewer Language(s): English, Spanish, Mandarin, Cantonese (PDF)
06/05/2020 12:00 AM EDT
Source: University of California, San Francisco (UCSF). Published: 6/5/2020. This is a self-report, administered questionnaire collected via REDCap (Research Electronic Data Capture system) to assess the costs and socioeconomic consequences of having COVID-19 or COVID-19 like symptoms. Population: Adults Only Length: Approximately 30 questions Time to Complete: 20 minutes Mode of Administration: Face-to-face Telephone Administered by: Trained Lay Examiner/Interviewer Language(s): English, Spanish, Mandarin, Cantonese (PDF)
05/01/2020 12:00 AM EDT
Source: University of Utah. Published: 5/1/2020. This survey seeks to understand sources of COVID-19 health information access and trust of those sources by minority communities to assess barriers to health information. It assesses the impact of COVID-19 on the individual, access to PPE (personal protective equipment) at work, prevention behaviors understanding, and barriers to implementing behaviors. Population: Adults Only Length: 58 questions Time to Complete: 2 to 5 minutes Mode of Administration: Online (e.g., computer-assisted interview) Administered by: Self Administered Special Considerations: Self administered via system such as REDCap. Can also be administered by intact person over the phone. Language(s): English, Spanish (PDF)
03/25/2020 12:00 AM EDT
Source: University of California, San Francisco (UCSF). Published: 3/25/2020. This is a self-report, administered questionnaire collected via REDCap (Research Electronic Data Capture system) to assess experiences with non-pharmaceutical public health interventions to mitigate community transmission of COVID-19 such as stay-at-home/shelter-in-place, self-isolation, and quarantine on high-risk populations (primarily those who are low-income, non-U.S. born, or for whom English is a second language). The questionnaire covers several key domains, including 1) Demographics; 2) Health Literacy; 3) Perceived Stress for the individual and household; 4) Health Risk Belief; 5) Access to healthcare, including telehealth; 6) Barriers to self-isolation; 7) Changes in socioeconomic status; and 8) Unmet social needs. Special attention is paid to determinants rooted in education, income, safety, food security, and housing. Population: Adults Only Length: Eight sections, approximately 100 questions Time to Complete: 45 minutes Mode of Administration: Face-to-face Telephone Administered by: Trained Lay Examiner/Interviewer Language(s): English, Spanish, Mandarin, Cantonese (PDF)
.png)
No hay comentarios:
Publicar un comentario